Inactief instrument

Koers Alexza Pharmaceuticals, Inc.

Aandelen

slotkoers Nasdaq Andere beurzen
- ^USD	-

Alexza Pharmaceuticals : Reports Fourth Quarter and Year End 2015 Financial Results	28-03-16
Alexza Pharmaceuticals : to Report 2015 Year End Financial Results and Provide Company Update on Monday, March 28, 2016	15-03-16
Alexza Pharmaceuticals : Receives Positive Nasdaq Listing Determination	09-03-16
Alexza Pharmaceuticals : Confirms Grupo Ferrer Non-binding Letter of Intent	27-02-16
Alexza Pharmaceuticals : Reacquires U.S. Commercial Rights for ADASUVE® (loxapine) inhalation powder	24-02-16

Managers	Titel	Leeftijd	Van
Stacy Palermini DFI	Director of Finance/CFO	-	01-01-03
Tatjana Naranda PSD	President	-	01-01-05
Wolfgang Schmidt PRN	Corporate Officer/Principal	-	01-05-19

Besturend	Titel	Leeftijd	Van
Jorge Ramentol Massana BRD	Director/Board Member	-	21-06-16
Joan Fanés Trillo BRD	Director/Board Member	-	21-06-16
Sergio Ferrer-Salat Serra di Migni BRD	Director/Board Member	-	21-06-16

Sector

	Vaira. 1 jan.	Kapi.
REGENERON PHARMACEUTICALS, INC.	+8,96%	105 mld.
VERTEX PHARMACEUTICALS INCORPORATED	-1,43%	104 mld.
ARGENX SE	+4,40%	22,94 mld.
BIONTECH SE	-12,15%	22,34 mld.
GENMAB A/S	-4,36%	19,25 mld.
WUXI APPTEC CO., LTD.	-39,98%	17,08 mld.
BEIGENE, LTD.	-10,04%	16,96 mld.
SAREPTA THERAPEUTICS, INC.	+38,61%	12,63 mld.
VIKING THERAPEUTICS, INC.	+313,59%	8,49 mld.